Exclusive

Publication

Byline

US Patent Issued to Exelixis on July 14 for "Crystalline forms and salt forms of a kinase inhibitor" (California, Indiana Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,809, issued on July 14, was assigned to Exelixis Inc. (Alameda, Calif.). "Crystalline forms and salt forms of a kinase inhibitor" was inven... Read More


US Patent Issued on July 14 for "Method for the preparation of sulfinpyrazone" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,810, issued on July 14. "Method for the preparation of sulfinpyrazone" was invented by Yu Feng (Jiaxing, China), Wei Qian (Jiaxing, China),... Read More


US Patent Issued to MannKind on July 14 for "Microcrystalline diketopiperazine compositions and methods" (Connecticut, New York Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,811, issued on July 14, was assigned to MannKind Corp. (Danbury, Conn.). "Microcrystalline diketopiperazine compositions and methods" was i... Read More


US Patent Issued to Cornell University on July 14 for "18 F-labeled triazole containing PSMA inhibitors" (New York Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,812, issued on July 14, was assigned to Cornell University (Ithaca, N.Y.). "18 F-labeled triazole containing PSMA inhibitors" was invented ... Read More


US Patent Issued to TANABE PHARMA on July 14 for "Triazine compound salt, crystal form thereof, and production method therefor" (Japanese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,813, issued on July 14, was assigned to TANABE PHARMA Corp. (Osaka, Japan). "Triazine compound salt, crystal form thereof, and production m... Read More


US Patent Issued to Novartis on July 14 for "Synthesis of prostate specific membrane antigen (PSMA) ligands" (Austrian Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,814, issued on July 14, was assigned to Novartis AG (Basel, Switzerland). "Synthesis of prostate specific membrane antigen (PSMA) ligands" ... Read More


US Patent Issued to Insmed on July 14 for "Linear dipeptidyl peptidase 1 inhibitors and uses thereof" (New Jersey Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,815, issued on July 14, was assigned to Insmed Inc. (Bridgewater, N.J.). "Linear dipeptidyl peptidase 1 inhibitors and uses thereof" was in... Read More


US Patent Issued to LG Display on July 14 for "Organic light emitting device" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,816, issued on July 14, was assigned to LG Display Co. Ltd. (Seoul, South Korea). "Organic light emitting device" was invented by Su-Na Cho... Read More


US Patent Issued to PHARMALA BIOTECH on July 14 for "Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB)" (Canadian Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,817, issued on July 14, was assigned to PHARMALA BIOTECH INC. (Vancouver, Canada). "Processes for the preparation of the enantiomers of 3,4... Read More


US Patent Issued to Institute of Science Tokyo, Fukushima Medical University, Taiyo Nippon Sanso on July 14 for "Radioactive halogen labeling precursor compound" (Japanese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,818, issued on July 14, was assigned to Institute of Science Tokyo (Tokyo), Fukushima Medical University (Fukushima, Japan) and Taiyo Nippon... Read More